FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898825364> ?p ?o ?g. }

• W2898825364 endingPage "129" @default.
• W2898825364 startingPage "123" @default.
• W2898825364 abstract "Irinotecan is effective for metastatic colorectal cancer (mCRC). SN-38 is an active metabolite of irinotecan, which is formed by carboxylesterase and inactivated by UDP-glucuronyltransferase (UGT) 1A1. The UGT enzyme activity is reduced in patients with homozygous mutation in UGT1A1 genes (*6/*6, *28/*28 and *6/*28); thus dose reduction is required for prevention of severe adverse events associated with irinotecan. The present study was designed to investigate the relationship between UGT1A1 polymorphisms and the incidence of adverse events or the therapeutic effect in mCRC patients who received irinotecan. Sixty-three mCRC patients who received irinotecan during January 2014 and May 2018 were the subjects of this study. The incidence of adverse events, including diarrhea and neutropenia, and the therapeutic effect of irinotecan were compared among homozygous group, heterozygous group and wild-type group. The initial dose of irinotecan was 150 mg/m2 in the heterozygous group and wild-type group, while the dose was reduced by 20% (120 mg/m2) in the homozygous group. The UGT1A1 polymorphisms occurred in 15.9%, 33.3%, and 50.8% for homozygous group, heterozygous group, and wild-type group, respectively. The average dose of irinotecan during overall cycles was not significantly different among three groups, despite the reduction of initial dose in homozygous group. There were no significant differences in the incidence rates of adverse events, tumor response, or time to treatment failure among three groups. The present study demonstrated that dose reduction by 20% ensured safety and efficacy of irinotecan in mCRC patients with homozygous mutation in UGT1A1 genes." @default.
• W2898825364 created "2018-11-09" @default.
• W2898825364 creator A5026657616 @default.
• W2898825364 creator A5029164270 @default.
• W2898825364 creator A5061553422 @default.
• W2898825364 creator A5061881778 @default.
• W2898825364 creator A5076715179 @default.
• W2898825364 creator A5077426727 @default.
• W2898825364 creator A5081174788 @default.
• W2898825364 date "2018-10-30" @default.
• W2898825364 modified "2023-09-26" @default.
• W2898825364 title "Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer" @default.
• W2898825364 cites W1963555830 @default.
• W2898825364 cites W1966170008 @default.
• W2898825364 cites W1982728538 @default.
• W2898825364 cites W1991736137 @default.
• W2898825364 cites W2006838800 @default.
• W2898825364 cites W2009387119 @default.
• W2898825364 cites W2012006000 @default.
• W2898825364 cites W2019607817 @default.
• W2898825364 cites W2058562246 @default.
• W2898825364 cites W2095201384 @default.
• W2898825364 cites W2095822339 @default.
• W2898825364 cites W2110650955 @default.
• W2898825364 cites W2115208364 @default.
• W2898825364 cites W2128447158 @default.
• W2898825364 cites W2128573586 @default.
• W2898825364 cites W2132545630 @default.
• W2898825364 cites W2133399075 @default.
• W2898825364 cites W2150914452 @default.
• W2898825364 cites W2161069288 @default.
• W2898825364 cites W2204496882 @default.
• W2898825364 cites W2314205992 @default.
• W2898825364 cites W2331268156 @default.
• W2898825364 cites W2389239223 @default.
• W2898825364 cites W2416798156 @default.
• W2898825364 doi "https://doi.org/10.1007/s00280-018-3711-8" @default.
• W2898825364 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6373181" @default.
• W2898825364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30377777" @default.
• W2898825364 hasPublicationYear "2018" @default.
• W2898825364 type Work @default.
• W2898825364 sameAs 2898825364 @default.
• W2898825364 citedByCount "24" @default.
• W2898825364 countsByYear W28988253642019 @default.
• W2898825364 countsByYear W28988253642020 @default.
• W2898825364 countsByYear W28988253642021 @default.
• W2898825364 countsByYear W28988253642022 @default.
• W2898825364 countsByYear W28988253642023 @default.
• W2898825364 crossrefType "journal-article" @default.
• W2898825364 hasAuthorship W2898825364A5026657616 @default.
• W2898825364 hasAuthorship W2898825364A5029164270 @default.
• W2898825364 hasAuthorship W2898825364A5061553422 @default.
• W2898825364 hasAuthorship W2898825364A5061881778 @default.
• W2898825364 hasAuthorship W2898825364A5076715179 @default.
• W2898825364 hasAuthorship W2898825364A5077426727 @default.
• W2898825364 hasAuthorship W2898825364A5081174788 @default.
• W2898825364 hasBestOaLocation W28988253641 @default.
• W2898825364 hasConcept C120665830 @default.
• W2898825364 hasConcept C121332964 @default.
• W2898825364 hasConcept C121608353 @default.
• W2898825364 hasConcept C126322002 @default.
• W2898825364 hasConcept C143998085 @default.
• W2898825364 hasConcept C149151106 @default.
• W2898825364 hasConcept C197934379 @default.
• W2898825364 hasConcept C2776694085 @default.
• W2898825364 hasConcept C2777063308 @default.
• W2898825364 hasConcept C2777477808 @default.
• W2898825364 hasConcept C2779682216 @default.
• W2898825364 hasConcept C2780259306 @default.
• W2898825364 hasConcept C526805850 @default.
• W2898825364 hasConcept C55493867 @default.
• W2898825364 hasConcept C61511704 @default.
• W2898825364 hasConcept C71924100 @default.
• W2898825364 hasConcept C86803240 @default.
• W2898825364 hasConcept C90924648 @default.
• W2898825364 hasConcept C98274493 @default.
• W2898825364 hasConceptScore W2898825364C120665830 @default.
• W2898825364 hasConceptScore W2898825364C121332964 @default.
• W2898825364 hasConceptScore W2898825364C121608353 @default.
• W2898825364 hasConceptScore W2898825364C126322002 @default.
• W2898825364 hasConceptScore W2898825364C143998085 @default.
• W2898825364 hasConceptScore W2898825364C149151106 @default.
• W2898825364 hasConceptScore W2898825364C197934379 @default.
• W2898825364 hasConceptScore W2898825364C2776694085 @default.
• W2898825364 hasConceptScore W2898825364C2777063308 @default.
• W2898825364 hasConceptScore W2898825364C2777477808 @default.
• W2898825364 hasConceptScore W2898825364C2779682216 @default.
• W2898825364 hasConceptScore W2898825364C2780259306 @default.
• W2898825364 hasConceptScore W2898825364C526805850 @default.
• W2898825364 hasConceptScore W2898825364C55493867 @default.
• W2898825364 hasConceptScore W2898825364C61511704 @default.
• W2898825364 hasConceptScore W2898825364C71924100 @default.
• W2898825364 hasConceptScore W2898825364C86803240 @default.
• W2898825364 hasConceptScore W2898825364C90924648 @default.
• W2898825364 hasConceptScore W2898825364C98274493 @default.
• W2898825364 hasIssue "1" @default.
• W2898825364 hasLocation W28988253641 @default.
• W2898825364 hasLocation W28988253642 @default.

• next